EUVIMEDEUVIMED entdecken
Open Access

ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis

Juan Tao, Qingyu Cheng, Pinjie Zhang, Guizhen Yu, Qi Chen, Manwen Yang, Qiqin Wu, Haopeng Fang, Haibo Wu, Xiaoyuan Song, Zhu Chen, Min Chen und 3 weitere

International Journal of Biological Sciences · 04.02.2026 · 22 (5) · 2343-2360

DOI: 10.7150/ijbs.118613 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 04.02.2026. Verfasst von Juan Tao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, The First Affiliated Hospital of the USTC, Division of Life Sciences and Medicine, University of Science a…. Hauptthemen laut MEDLINE: Annexin A1, Lupus Nephritis, Macrophages, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Annexin A1Lupus NephritisMacrophagesTOR Serine-Threonine KinasesFatty Acid-Binding ProteinsAnimalsMiceHumansFibrosisFemaleReceptors, Formyl PeptideKidneyReceptors, LipoxinPeptides

Stichwörter der Autor:innen

annexin A1lipid metabolic reprogramminglupus nephritismacrophagerenal fibrosis

Substanzen

Annexin A1TOR Serine-Threonine KinasesFatty Acid-Binding ProteinsANXA1 protein, humanannexin A1 peptide (2-26)FPR2 protein, humanReceptors, Formyl PeptideReceptors, LipoxinPeptides

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, The First Affiliated Hospital of the USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei 230071, China.
  • Emergency Department, Peking University Shenzhen Hospital, Shenzhen 518000, China.
  • Kidney Disease Center, the First Affiliated Hospital, College of Medicine, Zhejiang University; Key Laboratory of Kidney Disease Prevention and Control Technology, Zhejiang Province; Institute of Nephrology, Zhejiang Un…
  • Department of Dermatology, The First Affiliated Hospital of the USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230001, China.
  • Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei 230027, China.

Zitieren

APA

Tao, J., Cheng, Q., Zhang, P., Yu, G., Chen, Q., Yang, M., Wu, Q., Fang, H., Wu, H., Song, X., Chen, Z., Chen, M., Meng, X., Lei, M., & Jin, T. (2026). ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis. International Journal of Biological Sciences, 22(5), 2343-2360. https://doi.org/10.7150/ijbs.118613

Vancouver

Tao J, Cheng Q, Zhang P, Yu G, Chen Q, Yang M, et al. ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis. International Journal of Biological Sciences. 2026;22(5):2343-2360. doi:10.7150/ijbs.118613

BibTeX
@article{Tao2026,
  author = {Tao, Juan and Cheng, Qingyu and Zhang, Pinjie and Yu, Guizhen and Chen, Qi and Yang, Manwen and Wu, Qiqin and Fang, Haopeng and Wu, Haibo and Song, Xiaoyuan and Chen, Zhu and Chen, Min and Meng, Xiaoming and Lei, Mingxing and Jin, Tengchuan},
  title = {ANXA1-mediated mTOR/FABP4 Inhibition Drives Antifibrotic Macrophage Reprogramming in Lupus Nephritis},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  volume = {22},
  number = {5},
  pages = {2343--2360},
  doi = {10.7150/ijbs.118613}
}
Kostenlos starten →